Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Sep 01, 2008 (Vol. 28, No. 15)

CMR Home Page

  • Well organized, nicely focused
  • None
The website for The Institute for Genome Research (TIGR) has undergone many transformations over the years and each one has been an improvement. The latest iteration, dubbed the Comprehensive Microbial Resource (CMR), scores big in its tidy interface and in the easy access it provides to sequences from publicly available prokaryotic genomes. At press time, this included 384 complete genomes (prokaryotic, archaeans, and viruses) and 17 draft prokaryotic genomes. The site excels in anticipating the needs of its users. For example, Genome Tools tidily organizes lists of genomes, summary information, graphics displays, and analysis tools. Search options allow users to locate genes, genomes, sequences, and specific text. Comparative tools include protein homologies, alignments, and attributes. Sequences can be easily downloaded by FTP. Is there anything these folks haven’t thought of? I think not.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »